Literature DB >> 2200520

Formation of a stable L-ascorbic acid alpha-glucoside by mammalian alpha-glucosidase-catalyzed transglucosylation.

I Yamamoto1, N Muto, E Nagata, T Nakamura, Y Suzuki.   

Abstract

Enzymatic transglucosylation from maltose to L-ascorbic acid (AA) with mammalian tissue homogenates was determined by a high-performance liquid chromatography method and compared with the reaction catalyzed by alpha-glucosidase from Aspergillus niger. The homogenates of small intestine and kidney had a high transglucosylase activity to form a new type of glucosylated AA, which was associated with alpha-glucosidase activity. The new compound was demonstrated to be an equimolar conjugate of AA and glucose by the spectral and quantitative analyses. In particular, it showed a high stability in a neutral solution and no reducing activity toward cytochrome c and a dye. These properties were very different from those of AA and L-ascorbic acid alpha-glucoside formed with alpha-glucosidase from A. niger, but they were consistent with those of L-ascorbic acid 2-O-phosphate and L-ascorbic acid 2-O-sulfate. Moreover, it exhibited a reducing power associated with AA after mild acid hydrolysis or treatment with rat intestinal alpha-glucosidase. These results indicate that it should be assigned the 2-O-alpha-glucoside structure. Consequently, it is concluded that mammalian alpha-glucosidase is able to form a very stable and nonreducing form of glucosylated AA through a specific transglucosylation reaction distinct from that of microbial alpha-glucosidase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200520     DOI: 10.1016/0304-4165(90)90171-r

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Novel alpha-glucosidase from Aspergillus nidulans with strong transglycosylation activity.

Authors:  Naoki Kato; Sachie Suyama; Masao Shirokane; Masashi Kato; Tetsuo Kobayashi; Norihiro Tsukagoshi
Journal:  Appl Environ Microbiol       Date:  2002-03       Impact factor: 4.792

2.  Drug nanoparticle formulation using ascorbic Acid derivatives.

Authors:  Kunikazu Moribe; Waree Limwikrant; Kenjirou Higashi; Keiji Yamamoto
Journal:  J Drug Deliv       Date:  2011-04-26

3.  Glucansucrase Gtf180-ΔN of Lactobacillus reuteri 180: enzyme and reaction engineering for improved glycosylation of non-carbohydrate molecules.

Authors:  Tim Devlamynck; Evelien M Te Poele; Xiangfeng Meng; Sander S van Leeuwen; Lubbert Dijkhuizen
Journal:  Appl Microbiol Biotechnol       Date:  2016-04-06       Impact factor: 4.813

4.  Engineering a Carbohydrate-processing Transglycosidase into Glycosyltransferase for Natural Product Glycodiversification.

Authors:  Chaoning Liang; Yi Zhang; Yan Jia; Youhai Li; Shikun Lu; Jian-Ming Jin; Shuang-Yan Tang
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

5.  Eliminating hydrolytic activity without affecting the transglycosylation of a GH1 β-glucosidase.

Authors:  Pontus Lundemo; Eva Nordberg Karlsson; Patrick Adlercreutz
Journal:  Appl Microbiol Biotechnol       Date:  2016-09-27       Impact factor: 4.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.